The Food and Drug Administration (FDA) has delayed a rule that would regulate off-label drug and device promotion. Read more
On April 3, 2013, the First Circuit Court of Appeals ruled that drug manufacturer Pfizer, Inc.’s fraudulent marketing of the drug Neurontin directly caused plaintiffs Kaiser Foundation Healt... Read more
Blue Cross Blue Shield entities from Texas, Illinois, New Mexico and Oklahoma (hereinafter “BCBS”) have filed a lawsuit against Pfizer over its marketing of three drugs. The allegations in t... Read more
Utah’s Attorney General has filed suit against Johnson & Johnson and AstraZeneca for the illegal off-label marketing of anti-psychotic drugs. The suit, filed in a Utah state court last m... Read more
The Swiss pharmaceutical company Novartis AG will pay $72.5 million to settle a whistleblower lawsuit accusing it of improperly billing government programs for unapproved uses of a cystic fi... Read more
The U.S. Department of Justice has reached two settlements with pharmaceutical companies that will call for a total of more than $100 million in penalties under the False Claims Act and the... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.